Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Novo Nordisk trims Outlook

Digest more
 · 1h · on MSN
Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly
Pedersen, Maggie Fick and Bhanvi Satija COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year forecasts on Wednesday as sales growth of its blockbuster obesity drugs slows, leaving investors worried the firm is losing ground to U.

Continue reading

 · 20h · on MSN
Eli Lilly, Novo Nordisk negotiating deal with Trump administration on obesity drug prices
NewsNation · 6m
Eli Lilly, Novo Nordisk near deal on weight loss drug costs: Report
Devdiscourse
20m

Novo Nordisk Battles Market Shifts Amid Obesity Drug Rivalry

Novo Nordisk lowered its forecasts due to slowing sales of its obesity drugs amid competition from Eli Lilly and generic ...
Fierce Pharma
1h

After shaky Q3, Novo's new CEO says company's diabetes and obesity turnaround is a 'marathon, not a sprint'

Less than three months into his tenure, Novo Nordisk’s new CEO has undeniably left his mark on the company, launching a ...
4m

Novo Nordisk Slides as GLP-1 Fatigue and Pricing Risks Cloud 2025 Outlook

Shares of Novo Nordisk (NYSE:NVO) slipped about 1% on Wednesday morning after the company issued a cautious outlook, even ...
2don MSN

Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech

The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms